Association of miR-27aA>G, miR-423C>a, miR-449bA>G, and miR-604A>G Polymorphisms with Risk of Recurrent Implantation Failure
Tóm tắt
Recurrent implantation failure (RIF) is defined when pregnancy failure occurs after two consecutive in vitro fertilization-embryo transfers to the endometrium using at least four high-quality embryos in women. MicroRNAs are well-known function modulators and are involved in many diseases. Recently, studies on microRNA and recurrent pregnancy loss (RPL) have been actively carried out; however, single nucleotide polymorphisms of miRNA in RPL are not well known. Therefore, we set the aim of this study to identify whether polymorphisms in miRNAs that miR-27aA>G, miR-423C>A, miR-449bA>G, and miR-604A>G are risk factors for idiopathic recurrent implantation failure (RIF) in Korean women. Genotyping was assessed with a polymerase chain reaction–restriction fragment length polymorphism assay. We examined polymorphisms in four miRNA genes: miR-27aA>G, miR-423C>A, miR-449bA>G, and miR-604A>G. We found that the miR-27aA>G, miR-449bA>G, and miR-604A>G polymorphisms were significantly associated with a risk of RIF. In addition, the miR-27aA>G and miR-449bA>G polymorphisms were associated with the frequency of implantation failures. Specifically, the miR-449bAG+GG genotype was associated with RIF prevalence (total RIF: adjusted odd ratio [AOR] = 1.584, 95% CI = 1.008–2.490, P = 0.046; IF ≥ 3 group: AOR = 1.747, 95% CI = 1.088–2.803, P = 0.021; IF ≥ 4: AOR = 1.932, 95% CI = 1.122–3.327, P = 0.018). Based on these results, the miR-449b A>G may be a predisposing factor to RIF susceptibility. However, the mechanism underlying the function of miR-449b A>G in RIF remains to be determined and further studies are needed to improve understanding of the roles of miR-449b A>G, using a larger and more heterogeneous cohort.
Tài liệu tham khảo
Coughlan C, Ledger W, Wang Q, et al. Recurrent implantation failure: definition and management. Reprod BioMed Online. 2014;28:14–38.
Stephenson MD, Fluker MR. Treatment of repeated unexplained in vitro fertilization failure with intravenous immunoglobulin: a randomized, placebo-controlled Canadian trial. Fertil Steril. 2000;74:1108–13.
Lledo B, Turienzo A, Ortiz JA, Morales R, ten J, Llácer J, et al. Negative effect of P72 polymorphism on p53 gene in IVF outcome in patients with repeated implantation failure and pregnancy loss. J Assist Reprod Genet. 2014;31:169–72.
Cho SH, Chung KW, Kim JO, et al. Association of miR-146aC>G, miR-149C>T, miR-196a2T>C, and miR-499A>G polymorphisms with risk of recurrent implantation failure in Korean women. Eur J Obstet Gynecol Reprod Biol. 2016;202:14–9.
Laufer N, Simon A. Recurrent implantation failure: current update and clinical approach to an ongoing challenge. Fertil Steril. 2012;97:1019–20.
Simon A, Laufer N. Repeated implantation failure: clinical approach. Fertil Steril. 2012;97:1039–43.
Wang H, Dey SK. Roadmap to embryo implantation: clues from mouse models. Nat Rev Genet. 2006;7:185–99.
Margalioth EJ, Ben-Chetrit A, Gal M, et al. Investigation and treatment of repeated implantation failure following IVF-ET. Hum Reprod. 2006;21:3036–43.
Choi Y, Kim HR, Lim EJ, et al. Integrative analyses of uterine transcriptome and microRNAome reveal compromised LIF-STAT3 signaling and progesterone response in the endometrium of patients with recurrent/repeated implantation failure (RIF). PLoS One. 2016;11:e0157696.
Revel A, Achache H, Stevens J, Smith Y, Reich R. MicroRNAs are associated with human embryo implantation defects. Hum Reprod. 2011;26:2830–40.
Shi C, Shen H, Fan LJ, et al. Endometrial microRNA signature during the window of implantation changed in patients with repeated implantation failure. Chin Med J. 2017;130:566–73.
Guo Y, Sun J, Lai D. Role of microRNAs in premature ovarian insufficiency. Reprod Biol Endocrinol. 2017;15:38.
Jeon YJ, Kim YR, Lee BE, Cha SH, Moon MJ, Oh D, et al. Association of five common polymorphisms in the plasminogen activator inhibitor-1 gene with primary ovarian insufficiency. Fertil Steril. 2014;101:825–32.
Kim YR, Jeon YJ, Kim HS, Kim JO, Moon MJ, Ahn EH, et al. Association study of five functional polymorphisms in matrix metalloproteinase-2, -3, and -9 genes with risk of primary ovarian insufficiency in Korean women. Maturitas. 2015;80:192–7.
Hui A, How C, Ito E, et al. Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies. BMC Cancer. 2011;11:500.
Taguchi YH. MicroRNA-mediated regulation of target genes in several brain regions is correlated to both microRNA-targeting-specific promoter methylation and differential microRNA expression. BioData Min. 2013;6:11.
Shin JM, Lim W, Lee K-M, et al. Disease-miRNAdb: a manually-curated database for the investigation of the microRNA-human disease relationship. Genes Genom. 2017;39:1419–24.
Archanioti P, Gazouli M, Theodoropoulos G, et al. Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease. J Crohns Colitis. 2011;5:520–4.
Huang SM, Zhao X, Zhao XM, Wang XY, Li SS, Zhu YH. Biological mechanism analysis of acute renal allograft rejection: integrated of mRNA and microRNA expression profiles. Int J Clin Exp Med. 2014;7:5170–80.
Xia W, Cao G, Shao N. Progress in miRNA target prediction and identification. Sci China C Life Sci. 2009;52:1123–30.
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.
Esau CC, Monia BP. Therapeutic potential for microRNAs. Adv Drug Deliv Rev. 2007;59:101–14.
Rah H, Chung KW, Ko KH, et al. miR-27a and miR-449b polymorphisms associated with a risk of idiopathic recurrent pregnancy loss. PLoS One. 2017;12:e0177160.
Braza-Boïls A, Marí-Alexandre J, Gilabert J, et al. MicroRNA expression profile in endometriosis: its relation to angiogenesis and fibrinolytic factors. Hum Reprod. 2014;29:978–88.
Wessels JM, Edwards AK, Khalaj K, et al. The microRNAome of pregnancy: deciphering miRNA networks at the maternal-fetal interface. PLoS One. 2013;8:e72264.
Zhang M, Jin M, Yu Y, et al. Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population. Eur J Cancer Care (Engl). 2012;21:274–80.
Choi Y, Kim JO, Shim SH, et al. Genetic variation of methylenetetrahydrofolate reductase (MTHFR) and thymidylate synthase (TS) genes is associated with idiopathic recurrent implantation failure. PLoS One. 2016;11:e0160884.
Kim DH, Gim J-A, Mishra A, et al. SNP analysis of genes related to cholesterol metabolism and associated with late-onset Alzheimer’s disease. Genes Genom. 2017;39:593–600.
Ryu CS, Sakong JH, Ahn EH, et al. Association study of the three functional polymorphisms (TAS2R46G>A, OR4C16G>A, and OR4X1A>T) with recurrent pregnancy loss. Genes Genom. 2019;41:61–70.
Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics. 2003;19:376–82.
Green D, Karpatkin S. Role of thrombin as a tumor growth factor. Cell Cycle. 2010;9:656–61.
Tay JW, James I, Hughes QW, et al. Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy. BMC Res Notes. 2017;10:312.
Meijers JCM, Tekelenburg WLH, Bouma BN, et al. High levels of factor XI as a risk factor for venous thrombosis. New Eng J Med. 2000;342:696–701.
Tripodi A, Chantarangkul V, Martinelli I, et al. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood. 2004;104:3631–4.
Reddy NM, Hall SW, MacKintosh FR. Partial thromboplastin time: prediction of adverse events and poor prognosis by low abnormal values. Arch Intern Med. 1999;159:2706–10.
Martínez-Zamora MA, Creus M, Tassies D, Reverter JC, Civico S, Carmona F, et al. Reduced plasma fibrinolytic potential in patients with recurrent implantation failure after IVF and embryo transfer. Hum Reprod. 2011;26:510–6.
Stern C, Chamley L. Antiphospholipid antibodies and coagulation defects in women with implantation failure after IVF and recurrent miscarriage. Reprod BioMed Online. 2006;13:29–37.
Gerotziafas GT, Van Dreden P, Mathieu d'Argent E, et al. Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study. Thromb J. 2017;15:9.
Goossens K, Mestdagh P, Lefever S, van Poucke M, van Zeveren A, van Soom A, et al. Regulatory microRNA network identification in bovine blastocyst development. Stem Cells Dev. 2013;22:1907–20.
Wang M, Gao Y, Qu P, et al. Sperm-borne miR-449b influences cleavage, epigenetic reprogramming and apoptosis of SCNT embryos in bovine. Sci Rep. 2017;7:13403.
Stumpfova Z, Hezova R, Meli AC, et al. MicroRNA profiling of activated and tolerogenic human dendritic cells. Mediat Inflamm. 2014;2014:259689.